" class="no-js "lang="en-US"> Chiesi Group - Medtech Alert
Monday, August 18, 2025
Chiesi Group | Pharmtech Focus

Chiesi Group

About Chiesi Group

Chiesi Group

Chiesi is an international company originated in Parma, with 85 years of experience and a strong focus on research, development, production and commercialization of innovative therapeutic solutions in the Respiratory, Neonatology, Rare Diseases and Special Care Therapeutic Areas. We are value-oriented, passionate, supportive and a global family with nearly 6.000 employees and 29 affiliates who have a real impact on people’s lives in 90 countries around the world. With a turnover of nearly €2 billion sales, we are among the top 50 pharmaceutical companies in the world. Chiesi is the largest global pharmaceutical Group to be awarded B Corp Certification, a recognition of high social and environmental standards. We want to use business as a force for good and create a positive impact on people, environment and community.

Related Story

Chiesi Global Rare Diseases Announces FDA Approval of Lamzede®(velmanase alfa-tycv) for Alpha-Mannosidosis

February 17 2023

Chiesi Global Rare Diseases announced today that the US Food and Drug Administration (FDA) has […]

Orbia's Koura Business Opens World's First HFA 152a Medical Propellant Production Facility

April 1 2022

Koura, a global leader in the development, manufacture, and supply of fluoroproducts and technologies,[2] today opens […]